List of Tables
Table 1. Global Chagas Disease Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Chagas Disease Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Chagas Disease Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Chagas Disease Drug Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Chagas Disease Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Chagas Disease Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Chagas Disease Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Chagas Disease Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Chagas Disease Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Chagas Disease Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Chagas Disease Drug, Product Type & Application
Table 12. Global Key Manufacturers of Chagas Disease Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Chagas Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chagas Disease Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Chagas Disease Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Chagas Disease Drug Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Chagas Disease Drug Sales Market Share by Region (2020-2025)
Table 19. Global Chagas Disease Drug Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Chagas Disease Drug Sales Market Share by Region (2026-2031)
Table 21. Global Chagas Disease Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Chagas Disease Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Chagas Disease Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Chagas Disease Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Chagas Disease Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Chagas Disease Drug Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Chagas Disease Drug Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Chagas Disease Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Chagas Disease Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Chagas Disease Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Chagas Disease Drug Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Chagas Disease Drug Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Chagas Disease Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Chagas Disease Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Chagas Disease Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Chagas Disease Drug Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Chagas Disease Drug Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Chagas Disease Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Chagas Disease Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Chagas Disease Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Chagas Disease Drug Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Chagas Disease Drug Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Chagas Disease Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Chagas Disease Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Chagas Disease Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Chagas Disease Drug Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Chagas Disease Drug Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Chagas Disease Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Chagas Disease Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Chagas Disease Drug Sales (K Pcs) by Type (2020-2025)
Table 51. Global Chagas Disease Drug Sales (K Pcs) by Type (2026-2031)
Table 52. Global Chagas Disease Drug Sales Market Share by Type (2020-2025)
Table 53. Global Chagas Disease Drug Sales Market Share by Type (2026-2031)
Table 54. Global Chagas Disease Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Chagas Disease Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Chagas Disease Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Chagas Disease Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Chagas Disease Drug Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Chagas Disease Drug Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Chagas Disease Drug Sales (K Pcs) by Application (2020-2025)
Table 61. Global Chagas Disease Drug Sales (K Pcs) by Application (2026-2031)
Table 62. Global Chagas Disease Drug Sales Market Share by Application (2020-2025)
Table 63. Global Chagas Disease Drug Sales Market Share by Application (2026-2031)
Table 64. Global Chagas Disease Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Chagas Disease Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Chagas Disease Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Chagas Disease Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Chagas Disease Drug Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Chagas Disease Drug Price (USD/Pcs) by Application (2026-2031)
Table 70. AstraZeneca Plc Company Information
Table 71. AstraZeneca Plc Description and Business Overview
Table 72. AstraZeneca Plc Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. AstraZeneca Plc Chagas Disease Drug Product
Table 74. AstraZeneca Plc Recent Developments/Updates
Table 75. Bayer AG Company Information
Table 76. Bayer AG Description and Business Overview
Table 77. Bayer AG Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Bayer AG Chagas Disease Drug Product
Table 79. Bayer AG Recent Developments/Updates
Table 80. Daiichi Sankyo Co Ltd Company Information
Table 81. Daiichi Sankyo Co Ltd Description and Business Overview
Table 82. Daiichi Sankyo Co Ltd Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Daiichi Sankyo Co Ltd Chagas Disease Drug Product
Table 84. Daiichi Sankyo Co Ltd Recent Developments/Updates
Table 85. Eisai Co Ltd Company Information
Table 86. Eisai Co Ltd Description and Business Overview
Table 87. Eisai Co Ltd Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Eisai Co Ltd Chagas Disease Drug Product
Table 89. Eisai Co Ltd Recent Developments/Updates
Table 90. GlaxoSmithKline Plc Company Information
Table 91. GlaxoSmithKline Plc Description and Business Overview
Table 92. GlaxoSmithKline Plc Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. GlaxoSmithKline Plc Chagas Disease Drug Product
Table 94. GlaxoSmithKline Plc Recent Developments/Updates
Table 95. Grupo Praxis Pharmaceutical SA Company Information
Table 96. Grupo Praxis Pharmaceutical SA Description and Business Overview
Table 97. Grupo Praxis Pharmaceutical SA Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Grupo Praxis Pharmaceutical SA Chagas Disease Drug Product
Table 99. Grupo Praxis Pharmaceutical SA Recent Developments/Updates
Table 100. Humanigen Inc Company Information
Table 101. Humanigen Inc Description and Business Overview
Table 102. Humanigen Inc Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Humanigen Inc Chagas Disease Drug Product
Table 104. Humanigen Inc Recent Developments/Updates
Table 105. Kancera AB Company Information
Table 106. Kancera AB Description and Business Overview
Table 107. Kancera AB Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Kancera AB Chagas Disease Drug Product
Table 109. Kancera AB Recent Developments/Updates
Table 110. Merck & Co Inc Company Information
Table 111. Merck & Co Inc Description and Business Overview
Table 112. Merck & Co Inc Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Merck & Co Inc Chagas Disease Drug Product
Table 114. Merck & Co Inc Recent Developments/Updates
Table 115. Novartis AG Company Information
Table 116. Novartis AG Description and Business Overview
Table 117. Novartis AG Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Novartis AG Chagas Disease Drug Product
Table 119. Novartis AG Recent Developments/Updates
Table 120. Oblita Therapeutics BVBA Company Information
Table 121. Oblita Therapeutics BVBA Description and Business Overview
Table 122. Oblita Therapeutics BVBA Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Oblita Therapeutics BVBA Chagas Disease Drug Product
Table 124. Oblita Therapeutics BVBA Recent Developments/Updates
Table 125. Sanofi Company Information
Table 126. Sanofi Description and Business Overview
Table 127. Sanofi Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Sanofi Chagas Disease Drug Product
Table 129. Sanofi Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Chagas Disease Drug Distributors List
Table 133. Chagas Disease Drug Customers List
Table 134. Chagas Disease Drug Market Trends
Table 135. Chagas Disease Drug Market Drivers
Table 136. Chagas Disease Drug Market Challenges
Table 137. Chagas Disease Drug Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Chagas Disease Drug
Figure 2. Global Chagas Disease Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Chagas Disease Drug Market Share by Type: 2024 & 2031
Figure 4. Cz-007 Product Picture
Figure 5. Cz-008 Product Picture
Figure 6. D-121 Product Picture
Figure 7. DNDI-0690 Product Picture
Figure 8. EPLBS-1246 Product Picture
Figure 9. EPLBS-967 Product Picture
Figure 10. Others Product Picture
Figure 11. Global Chagas Disease Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 12. Global Chagas Disease Drug Market Share by Application: 2024 & 2031
Figure 13. Hospital
Figure 14. Clinic
Figure 15. Others
Figure 16. Global Chagas Disease Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Chagas Disease Drug Market Size (2020-2031) & (US$ Million)
Figure 18. Global Chagas Disease Drug Sales (2020-2031) & (K Pcs)
Figure 19. Global Chagas Disease Drug Average Price (USD/Pcs) & (2020-2031)
Figure 20. Chagas Disease Drug Report Years Considered
Figure 21. Chagas Disease Drug Sales Share by Manufacturers in 2024
Figure 22. Global Chagas Disease Drug Revenue Share by Manufacturers in 2024
Figure 23. Global 5 and 10 Largest Chagas Disease Drug Players: Market Share by Revenue in Chagas Disease Drug in 2024
Figure 24. Chagas Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Global Chagas Disease Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 26. North America Chagas Disease Drug Sales Market Share by Country (2020-2031)
Figure 27. North America Chagas Disease Drug Revenue Market Share by Country (2020-2031)
Figure 28. U.S. Chagas Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada Chagas Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe Chagas Disease Drug Sales Market Share by Country (2020-2031)
Figure 31. Europe Chagas Disease Drug Revenue Market Share by Country (2020-2031)
Figure 32. Germany Chagas Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France Chagas Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. Chagas Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy Chagas Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia Chagas Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Chagas Disease Drug Sales Market Share by Region (2020-2031)
Figure 38. Asia Pacific Chagas Disease Drug Revenue Market Share by Region (2020-2031)
Figure 39. China Chagas Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Japan Chagas Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. South Korea Chagas Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. India Chagas Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Australia Chagas Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Taiwan Chagas Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Indonesia Chagas Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Thailand Chagas Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Malaysia Chagas Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Philippines Chagas Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Latin America Chagas Disease Drug Sales Market Share by Country (2020-2031)
Figure 50. Latin America Chagas Disease Drug Revenue Market Share by Country (2020-2031)
Figure 51. Mexico Chagas Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Brazil Chagas Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Argentina Chagas Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Middle East and Africa Chagas Disease Drug Sales Market Share by Country (2020-2031)
Figure 55. Middle East and Africa Chagas Disease Drug Revenue Market Share by Country (2020-2031)
Figure 56. Turkey Chagas Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Saudi Arabia Chagas Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. UAE Chagas Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Global Sales Market Share of Chagas Disease Drug by Type (2020-2031)
Figure 60. Global Revenue Market Share of Chagas Disease Drug by Type (2020-2031)
Figure 61. Global Chagas Disease Drug Price (USD/Pcs) by Type (2020-2031)
Figure 62. Global Sales Market Share of Chagas Disease Drug by Application (2020-2031)
Figure 63. Global Revenue Market Share of Chagas Disease Drug by Application (2020-2031)
Figure 64. Global Chagas Disease Drug Price (USD/Pcs) by Application (2020-2031)
Figure 65. Chagas Disease Drug Value Chain
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
